a

4 {"} Sr eye ee
earl athe Meath head

(The folloving data are taken from an informal report by Dr. Conard dated 4/20/71)
e

‘severly ome $8.

THE CURRENT STATUS OF THYROID DISEASE AMONG
THE MARSHALLESE EXPOSED TO FALLOUT FROM
THE BRAVO TEST, MARCH 1, 1954

The current status may be updated as follows:
I.

1
W

.
‘y

-

‘

ek
a
toa

oa

Total - 19

2 .-

1.

.
‘
:
+ het alanine apntel dem. et at ~ ae
.
Te “as
.

4

Young Rongelepese exposed to fallout March 1, 1954, when they were
1 to 8 years of age,
(Estimated dose:
175 rads external gamma
plus 600 to 1400 rem internal irradiation.)

2,

3.

2

(11%)

Currently hypothyroid with minimal nodularity,
Responding satisfactorily to oral thyroid hormone
therepy.
"

3

(16%)

shows some enlargement of the remnant of thyroid
left from é partial thyroidectomy in 1964; as she
has not followed her post-operative thyroid hormone
regimen, there is question as to whether she shovld
have further surgery.

11

(58%)

Young people operated on for thyroid disease during
August 1969 and recovered.
Diegnoses:
Primary
benign adenonatous goiter in two and pepillery
adencma of serious grade malignancy in one,

3

(167%)

Have undergone surgery in the U. S. prior to 1969
because of nodular thyroid diseese; histologic
tumor.

Responding satisfactorily to oral thyroid

hormone therepy with one exception:

Oeete ot el ie all

e4
.

.
+

.

*

Vue

abe

Currently normal by clinical and biociiemical tests.
(There may be a slight unevenness of the gland in
one patient.)

diagnosis of adencmatous goiter and Huerthle cell

‘

’

.

we

‘

4

"eo nctemgstethiinbintais 9ene s tada

*

sey

‘iw

cod

.

A‘
a
“*
ee

owe
ee

anantsyow *

|

This patient

(None of six Ailinginae children expesed to an estimated external
dose of 69 rads have shown thyroid dysfunction, }
Surviving adult Kongelapese exposed to fallout.
(Estimated dose:
175 rads external plus 160 rem internal irradiation.)

1
ee eedlr ee fede.

II.

Total - 34

1.

Papillary carcinoma removed surgically at ape 41,
No recurrence.

Taking oral

thyroid hormone therapy.

1

DOE ARCHIVES
sy
-

’
_——

-

—_

~~:og
.

— <> 2Se oe =
- . - re 7th
se
em
7 ..
.
a

’

.
-

°

-

- a.

=

-- »
.

.‘—

—

ee ge

=

ne ge eae ee en ee — rer
— +
- . Jt
~~ - «=
. ae
.
oe
«
-

wea
‘
wee
+
~—a_*
~*
mle
e:7poate ts=
-.
. . o~
*
_~*™.
re:
a
ea
at se
:Fe
.
> *.
>
*
=
.
_—
<=
.
om

se
.
.

le

*,

.

- Fa
:

.

o.

-

+ 7
_”*
—-7.

at'*

+

ee tT eee eee
*- ~. > oe te
fu,
. .
:
-

-

we

. te
_——
- at

a

-

_¢

~e_
oat
-

-

Select target paragraph3